<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00067899</url>
  </required_header>
  <id_info>
    <org_study_id>OSVER (completed)</org_study_id>
    <nct_id>NCT00067899</nct_id>
  </id_info>
  <brief_title>Oxidative Stress and Vitamin E Requirements</brief_title>
  <official_title>Oxidative Stress and Vitamin E Requirements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if oxidative stress derived from cigarette smoking
      increases vitamin E requirements. The study will also assess the role of vitamin C in
      modulating vitamin E requirements. Vitamin E requirements will be assessed by measuring
      vitamin E in plasma as well as by measuring the excreted vitamin E metabolite in the urine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will be investigating the fractional disappearance rate of tocopherols in cigarette
      smokers compared to nonsmokers. This will be accomplished by supplementing individuals with
      deuterium labeled alpha- and gamma-tocopherols. Quantification of plasma tocopherols as well
      as urinary metabolites, alpha- and gamma-carboxy ethyl hydroxychromanol, will be determined
      using liquid chromatography/mass spectrometry analysis. In addition, the role of vitamin C as
      it pertains to its influence on the fraction disappearance rate of vitamin E will also be
      evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2000</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>99</enrollment>
  <condition>Smoking</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E with and without Vitamin C</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  non-smoking status or smokers (more than 1 pack per day)

          -  age: 18-35 y

          -  stable body weight, ranging between 80% and 130%,

          -  maintenance of normal exercise and activity patterns

          -  total cholesterol ≤ 7.758 mmol/L (300 mg/dl)

          -  triglyceride concentration ≤ 3.387 mmol/L (300 mg/dl)

        Subjects will be excluded if they fulfill any one of the following:

          -  antioxidant supplement users

          -  resting blood pressure above 160/105 mm Hg

          -  engaged in aerobic activity more than five hours per week

          -  vegetarian or other restrictive dietary requirements

          -  fasting blood glucose concentration of ≥ 7.77 mmol/L (140 mg/dl)

          -  history of diabetes or uremia

          -  other known metabolic disease or medication use known to affect lipid metabolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Linus Pauling Institute - Oregon State University</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <zip>97331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Traber MG, Winklhofer-Roob BM, Roob JM, Khoschsorur G, Aigner R, Cross C, Ramakrishnan R, Brigelius-Flohé R. Vitamin E kinetics in smokers and nonsmokers. Free Radic Biol Med. 2001 Dec 1;31(11):1368-74.</citation>
    <PMID>11728808</PMID>
  </reference>
  <reference>
    <citation>Dietrich M, Block G, Norkus EP, Hudes M, Traber MG, Cross CE, Packer L. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr. 2003 Jan;77(1):160-6.</citation>
    <PMID>12499336</PMID>
  </reference>
  <reference>
    <citation>Traber MG, van der Vliet A, Reznick AZ, Cross CE. Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? Clin Chest Med. 2000 Mar;21(1):173-87, x. Review.</citation>
    <PMID>10763098</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2003</study_first_submitted>
  <study_first_submitted_qc>September 5, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2003</study_first_posted>
  <last_update_submitted>June 17, 2013</last_update_submitted>
  <last_update_submitted_qc>June 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</investigator_affiliation>
    <investigator_full_name>Maret Traber</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cigarette smoking</keyword>
  <keyword>tocopherol</keyword>
  <keyword>bioavailability</keyword>
  <keyword>metabolism</keyword>
  <keyword>oxidative stress</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

